Advances in the differentiation of pluripotent stem cells into vascular cells

Area of Science:

• Biomedical Engineering
• Stem Cell Biology
• Cardiovascular Research

Background:

• Blood vessels are crucial for systemic transport, and their dysfunction contributes to major diseases like stroke and diabetes.
• Current animal models present limitations in translating findings to human vascular physiology and pathology.
• There is a significant need for advanced in vitro models to address the socio-economic burden of vascular diseases.

Purpose of the Study:

• To review the progress in establishing and differentiating induced pluripotent stem cells (iPSCs) into vascular cells.
• To explore the application of iPSC-derived vascular cells in disease modeling, drug screening, and regenerative medicine.
• To highlight the role of advanced technologies like omics analysis in this research field.

Main Methods:

• Summarizing recent advancements in iPSC establishment and directed differentiation protocols for vascular cell generation.
• Reviewing techniques for in vivo transplantation of iPSC-derived vascular cells.
• Incorporating findings on the use of omics analysis and high-throughput sequencing in studying iPSC-derived vascular cells.

Main Results:

• Induced pluripotent stem cells (iPSCs) provide a versatile human-based cellular resource.
• Established protocols enable the differentiation of iPSCs into various vascular cell types.
• iPSC-derived vascular cells show promise for in vitro disease modeling and preclinical applications.

Conclusions:

• iPSC technology offers a powerful platform for advancing human vascular research and developing novel therapeutic strategies.
• The use of iPSC-derived vascular cells facilitates more accurate disease modeling and drug discovery compared to traditional methods.
• Integration of high-throughput tools enhances the understanding and application of iPSC-based vascular research.